ym 022 has been researched along with leptin in 2 studies
| Studies (ym 022) | Trials (ym 022) | Recent Studies (post-2010) (ym 022) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
|---|---|---|---|---|---|
| 65 | 1 | 8 | 25,940 | 1,628 | 11,468 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attoub, S; Bado, A; Buyse, M; Goïot, H; Hervatin, F; Laigneau, JP; Le Marchand-Brustel, Y; Levasseur, S; Lewin, JM; Moizo, L | 1 |
| Attoub, S; Bado, A; Barbier, M; Cherbut, C; Galmiche, JP; Joubert, M; Laboisse, C | 1 |
2 other study(ies) available for ym 022 and leptin
| Article | Year |
|---|---|
Physiological role of cholecystokinin B/gastrin receptor in leptin secretion.
Topics: Adipose Tissue; Animal Feed; Animals; Benzodiazepines; Blood Glucose; Epididymis; Hormone Antagonists; Insulin; Leptin; Male; Proteins; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1999 |
Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Benzodiazepines; Colitis; Disease Models, Animal; Ethanolamines; Hormone Antagonists; Inflammatory Bowel Diseases; Leptin; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3; Receptors, Cholecystokinin; Severity of Illness Index | 2001 |